Reference
HPRA. Beovu (brolucizumab) - Important Safety Information from Novartis Ireland Ltd as approved by the HPRA (09.11.21) Internet Document : 10 Nov 2021. Available from: URL: https://www.hpra.ie/docs/default-source/default-document-library/important-safety-information-beovu-(brolucizumab).pdf?sfvrsn=0
Rights and permissions
About this article
Cite this article
Reducing risk of brolucizumab-related intraocular inflammation. Reactions Weekly 1884, 4 (2021). https://doi.org/10.1007/s40278-021-06325-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-06325-9